EVERSENSE E3

Serial Number 90886459
Registration 7356023
700

Registration Progress

Application Filed
Aug 17, 2021
Under Examination
Aug 29, 2023
Approved for Publication
Jul 4, 2023
Published for Opposition
Jul 4, 2023
Registered
Apr 9, 2024

Trademark Image

EVERSENSE E3

Basic Information

Serial Number
90886459
Registration Number
7356023
Filing Date
August 17, 2021
Registration Date
April 9, 2024
Published for Opposition
July 4, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 9, 2024
Registration
Registered
Classes
010

Rights Holder

Senseonics, Incorporated

03
Address
20451 Seneca Meadows Parkway
Germantown, MD 20876

Ownership History

Senseonics, Incorporated

Original Applicant
03
Germantown, MD

Senseonics, Incorporated

Owner at Publication
03
Germantown, MD

Senseonics, Incorporated

Original Registrant
03
Germantown, MD

Legal Representation

Attorney
R.J. Heher, Esq.

USPTO Deadlines

Next Deadline
1611 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-09)
Due Date
April 09, 2030
Grace Period Ends
October 09, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Apr 9, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 9, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 5, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 3, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 2, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 2, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 7, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 7, 2024 IUAF S USE AMENDMENT FILED Loading...
Jan 18, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 29, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 4, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 4, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 14, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 27, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 25, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 24, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 24, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 25, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 25, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Nov 25, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 21, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 21, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 21, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 19, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 19, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 19, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 18, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 6, 2021 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 5, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 20, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices sold therewith as a unit; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously measure and monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices that permit the wireless reporting and analysis of the concentration of glucose in the human body sold therewith as a unit; medical apparatus for monitoring glucose levels and integrated recorded computer software for use in calculating, reviewing, analyzing and displaying patient data sold therewith as a unit
First Use Anywhere: Mar 15, 2022
First Use in Commerce: Mar 15, 2022

Additional Information

Design Mark
The mark consists of the word "EVERSENSE" with a curvilinear line above the word integrated into the letter "V" in the word "EVERSENSE" and running the entire length above the word, followed by the superscript characters "E3" in italicized font.
Pseudo Mark
EVER SENSE E THREE

Classification

International Classes
010